ANDREW SHELTON: Open Payments
NPI 1477916583 · MARSHALL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 25 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $274 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $202 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 2 | $41 |
| Corcept Therapeutics | 2 | $34 |
| Seqirus USA Inc | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, Ozempic, MAVYRET, MOUNJARO, Korlym, Flucelvax, TZIELD, FANAPT.
Industry payments across NC — which companies pay providers there.
